Literature DB >> 18024835

Structure, evolution, and biology of the MUC4 mucin.

Pallavi Chaturvedi1, Ajay P Singh, Surinder K Batra.   

Abstract

Mucins are high-molecular-weight glycoproteins and are implicated in diverse biological functions. MUC4, a member of transmembrane mucin family, is expressed in airway epithelial cells and body fluids like saliva, tear film, ear fluid, and breast milk. In addition to its normal expression, an aberrant expression of MUC4 has been reported in a variety of carcinomas. Among various potential domains of MUC4, epidermal growth factor (EGF) -like domains are hypothesized to interact with and activate the ErbB2 receptors, suggesting an intramembrane-growth factor function for MUC4. The heavily glycosylated tandem repeat domain provides the structural rigidity to the extended extracellular region. MUC4, by virtue of its extended structure, serves as a barrier for some cell-cell and cell-extracellular matrix interactions and as a potential reservoir for certain growth factors. An intricate relationship between MUC4 and growth factor signaling is also reflected in the transcriptional regulation of MUC4. The MUC4 promoter has binding sites for different transcription factors, which are responsible for the regulation of its expression in different tissues. The interferon-gamma, retinoic acid, and transforming growth factor-beta signaling pathways regulate MUC4 expression in a partially interdependent manner. Taken together, all of these features of MUC4 strongly support its role as a potential candidate for diagnostic and therapeutic applications in cancer and other diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18024835      PMCID: PMC2835492          DOI: 10.1096/fj.07-9673rev

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  126 in total

1.  Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2.

Authors:  Victoria P Ramsauer; Vanessa Pino; Amjad Farooq; Coralie A Carothers Carraway; Pedro J I Salas; Kermit L Carraway
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

2.  MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms.

Authors:  A P Singh; S C Chauhan; M Andrianifahanana; N Moniaux; J L Meza; M C Copin; I van Seuningen; M A Hollingsworth; J P Aubert; S K Batra
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

3.  Membrane mucin Muc4 induces density-dependent changes in ERK activation in mammary epithelial and tumor cells: role in reversal of contact inhibition.

Authors:  Vanessa Pino; Victoria P Ramsauer; Pedro Salas; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  J Biol Chem       Date:  2006-08-04       Impact factor: 5.157

4.  MUC4 gene polymorphism and expression in women with implantation failure.

Authors:  Isabelle Koscinski; Stephane Viville; Nicole Porchet; Annie Bernigaud; Fabienne Escande; Andre Defossez; Marie-Pierre Buisine
Journal:  Hum Reprod       Date:  2006-06-28       Impact factor: 6.918

5.  IL-9 modulated MUC4 gene and glycoprotein expression in airway epithelial cells.

Authors:  Gautam Damera; Baoyun Xia; Hanumatha R Ancha; Goverdhan P Sachdev
Journal:  Biosci Rep       Date:  2006-02       Impact factor: 3.840

6.  Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).

Authors:  Subhash C Chauhan; Ajay P Singh; Fernanda Ruiz; Sonny L Johansson; Maneesh Jain; Lynette M Smith; Nicolas Moniaux; Surinder K Batra
Journal:  Mod Pathol       Date:  2006-07-28       Impact factor: 7.842

7.  Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16.

Authors:  Sekhar Duraisamy; Selvi Ramasamy; Surender Kharbanda; Donald Kufe
Journal:  Gene       Date:  2006-02-24       Impact factor: 3.688

8.  The mucin Muc4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3.

Authors:  Melanie Funes; Jamie K Miller; Cary Lai; Kermit L Carraway; Colleen Sweeney
Journal:  J Biol Chem       Date:  2006-05-11       Impact factor: 5.157

9.  MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.

Authors:  Hideaki Tsutsumida; Masamichi Goto; Shinichi Kitajima; Ichiro Kubota; Yasunobu Hirotsu; Joeji Wakimoto; Surinder K Batra; Kohzoh Imai; Suguru Yonezawa
Journal:  Lung Cancer       Date:  2006-11-28       Impact factor: 5.705

Review 10.  Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.

Authors:  Ajay P Singh; Pallavi Chaturvedi; Surinder K Batra
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

View more
  94 in total

Review 1.  Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.

Authors:  Partha Mukhopadhyay; Subhankar Chakraborty; Moorthy P Ponnusamy; Imayavaramban Lakshmanan; Maneesh Jain; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2011-01-26

Review 2.  Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.

Authors:  S Bafna; S Kaur; S K Batra
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

3.  Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense.

Authors:  Mehmet Kesimer; Margaret Scull; Brian Brighton; Genevieve DeMaria; Kimberlie Burns; Wanda O'Neal; Raymond J Pickles; John K Sheehan
Journal:  FASEB J       Date:  2009-02-03       Impact factor: 5.191

4.  Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region.

Authors:  Hannes Kutta; Andreas Willer; Philipp Steven; Lars Bräuer; Michael Tsokos; Friedrich Paulsen
Journal:  J Anat       Date:  2008-07-22       Impact factor: 2.610

Review 5.  Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.

Authors:  M Mimeault; S K Batra
Journal:  Gut       Date:  2008-10       Impact factor: 23.059

6.  Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.

Authors:  Takumi Kiwamoto; Toshihiko Katoh; Michael Tiemeyer; Bruce S Bochner; Christopher M Evans; William J Janssen; Mary E Brummet; Sherry A Hudson; Zhou Zhu
Journal:  J Allergy Clin Immunol       Date:  2014-12-12       Impact factor: 10.793

Review 7.  Muc4/MUC4 functions and regulation in cancer.

Authors:  Kermit L Carraway; George Theodoropoulos; Goldi A Kozloski; Coralie A Carothers Carraway
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

8.  The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms.

Authors:  Heather C Workman; Colleen Sweeney; Kermit L Carraway
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

Review 9.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

10.  The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells.

Authors:  Heather C Workman; Jamie K Miller; Ellen Q Ingalla; Rouminder P Kaur; Diane I Yamamoto; Laurel A Beckett; Lawrence Jt Young; Robert D Cardiff; Alexander D Borowsky; Kermit L Carraway; Colleen Sweeney; Kermit L Carraway
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.